To comprehensively evaluate the increased risk of clinically relevant toxicities, we listed the incidences of anti‐EGFR‐relevant toxicity focusing on diarrhea and skin changes in the affected area of the skin involved in radiotherapy (shown in Table 4). This evidence concerns the gene EGFR and neoplasm.